| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.26 | 0.09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |